Trade Summary

3 months ago, Patel Sujal M, serving as CEO, Pres,, Secretary, 10% owner at Nautilus Biotechnology, Inc. (NAUT), purchased 200,000 shares at $0.68 per share, for a total transaction value of $135,575.00. Following this transaction, Patel Sujal M now holds 17,436,232 shares of NAUT.

This purchase represents a 1.00% increase in Patel Sujal M's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Friday, September 5, 2025 and publicly disclosed via SEC Form 4 filing on Tuesday, September 9, 2025, 4 days after the trade was made.

Nautilus Biotechnology, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.